Suppr超能文献

tau:多种脑部疾病的促成因子,也是迅速发展的治疗策略的靶标。

Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies.

机构信息

Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA.

Department of Neurology and Weill Institute for Neurosciences, University of California, San Francisco, CA 94158, USA.

出版信息

Science. 2021 Feb 26;371(6532). doi: 10.1126/science.abb8255.

Abstract

Several lines of evidence implicate the protein tau in the pathogenesis of multiple brain disorders, including Alzheimer's disease, other neurodegenerative conditions, autism, and epilepsy. Tau is abundant in neurons and interacts with microtubules, but its main functions in the brain remain to be defined. These functions may involve the regulation of signaling pathways relevant to diverse biological processes. Informative disease models have revealed a plethora of abnormal tau species and mechanisms that might contribute to neuronal dysfunction and loss, but the relative importance of their respective contributions is uncertain. This knowledge gap poses major obstacles to the development of truly impactful therapeutic strategies. The current expansion and intensification of efforts to translate mechanistic insights into tau-related therapeutics should address this issue and could deliver better treatments for a host of devastating conditions.

摘要

有几条证据表明蛋白 tau 与多种脑部疾病的发病机制有关,包括阿尔茨海默病、其他神经退行性疾病、自闭症和癫痫。Tau 在神经元中含量丰富,并与微管相互作用,但它在大脑中的主要功能仍有待确定。这些功能可能涉及调节与多种生物过程相关的信号通路。有启发性的疾病模型揭示了大量异常的 tau 物种和机制,这些可能导致神经元功能障碍和丧失,但它们各自的贡献的相对重要性尚不确定。这一知识空白给真正有影响力的治疗策略的发展带来了重大障碍。目前,将机制见解转化为与 tau 相关的治疗方法的努力正在扩大和加强,应该解决这个问题,并为许多毁灭性疾病带来更好的治疗方法。

相似文献

2
Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies.tau 对神经元微管动态的调节:对 tau 病的影响。
Int J Biol Macromol. 2019 Jul 15;133:473-483. doi: 10.1016/j.ijbiomac.2019.04.120. Epub 2019 Apr 17.
4
Disease-modifying strategies in primary tauopathies.原发性 tau 病的疾病修饰策略。
Neuropharmacology. 2020 May 1;167:107842. doi: 10.1016/j.neuropharm.2019.107842. Epub 2019 Nov 5.
7
Tau phosphorylation and aggregation as a therapeutic target in tauopathies.tau 磷酸化和聚集作为 tau 病的治疗靶点。
CNS Neurol Disord Drug Targets. 2010 Dec;9(6):727-40. doi: 10.2174/187152710793237403.

引用本文的文献

4
PROTAC technology for prostate cancer treatment.用于前列腺癌治疗的PROTAC技术。
Acta Mater Med. 2025 Jan 7;4(1):99-121. doi: 10.15212/amm-2024-0075. Epub 2025 Jan 30.

本文引用的文献

2
Cryo-EM structures of tau filaments.tau 纤维的冷冻电镜结构。
Curr Opin Struct Biol. 2020 Oct;64:17-25. doi: 10.1016/j.sbi.2020.05.011. Epub 2020 Jun 27.
6
Targeting tau: Clinical trials and novel therapeutic approaches.针对 tau:临床试验和新的治疗方法。
Neurosci Lett. 2020 Jul 13;731:134919. doi: 10.1016/j.neulet.2020.134919. Epub 2020 May 4.
9
LRP1 is a master regulator of tau uptake and spread.LRP1 是 tau 摄取和扩散的主要调节因子。
Nature. 2020 Apr;580(7803):381-385. doi: 10.1038/s41586-020-2156-5. Epub 2020 Apr 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验